Enhanced cellular metabolism of very low density lipoprotein by simvastatin. A novel mechanism of action of HMG‐CoA reductase inhibitors

European Journal of Clinical Investigation

Volumn 24, Issue 3, 1994, Pages 173-178

  SEHAYEK, E ^a   BUTBUL, E ^a   AVNER, R ^a   LEVKOVITZ, H ^a   EISENBERG, S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CELL METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; LIPOPROTEIN METABOLISM; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; FEMALE; HUMAN; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LOVASTATIN; MALE; MIDDLE AGE; SIMVASTATIN;

EID: 0028306052     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1994.tb00984.x     Document Type: Article

References (26)

1. Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults
2. Mechanisms of formation of low density lipoproteins: metabolic pathways and their regulation
3. A receptor‐mediated pathway for cholesterol homeostasis
4. Metabolism of rat plasma very low density lipoprotein. II. Fate in circulation of apoprotein subunits
5. Mechanisms of primary hypercholesterolemia in humans
6. The low‐density lipoprotein receptor related protein: double agent or decoy?
7. HMG‐COA reductase inhibitors for treatment of hypercholesterolemia
8. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits
9. Mevinolin and colestipol stimulate receptor‐mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes
10. Lovastatin therapy reduces low density lipoprotein apo B levels in subjects with combined hyperlipidemia by reducing the production of apo B‐containing lipoproteins: Implications for the pathophysiology of apo B production
11. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
12. The metabolism of very low density lipoprotein proteins
13. Efficient trace labeling of proteins with iodine
14. Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts
15. Receptor mediated endocytosis of low‐density lipoprotein in cultured cells
16. .Protein measurement with the Folin phenol reagent
17. Phosphorus assay in column chromatography
18. The reliability of molecular weight determinations by dodecyl sulfate‐polyacrylamide gel electro‐phoreses
19. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia
20. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia
21. Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia
22. Lipolysis exposes unreactive endogenous apolipoprotein E‐3 in human and rat plasma very low density lipoprotein
23. Abnormal composition of hypertriglyceridemic very low density lipoprotein determines abnormal cell metabolism
24. Effects of lovastatin therapy on very‐low density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: Evidence for reduced assembly and secretion of triglyceride‐rich lipoproteins